Compare XNCR & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XNCR | VINP |
|---|---|---|
| Founded | 1997 | 2009 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 881.9M | 807.6M |
| IPO Year | 2013 | 2020 |
| Metric | XNCR | VINP |
|---|---|---|
| Price | $11.64 | $10.87 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $22.89 | $14.00 |
| AVG Volume (30 Days) | ★ 579.8K | 61.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.59% |
| EPS Growth | ★ 65.36 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $125,576,000.00 | N/A |
| Revenue This Year | N/A | $66.95 |
| Revenue Next Year | $6.52 | $20.64 |
| P/E Ratio | ★ N/A | $24.41 |
| Revenue Growth | ★ 13.65 | N/A |
| 52 Week Low | $6.92 | $8.66 |
| 52 Week High | $18.69 | $13.61 |
| Indicator | XNCR | VINP |
|---|---|---|
| Relative Strength Index (RSI) | 45.23 | 27.93 |
| Support Level | $11.02 | $10.56 |
| Resistance Level | $12.58 | $10.87 |
| Average True Range (ATR) | 0.88 | 0.54 |
| MACD | 0.02 | -0.14 |
| Stochastic Oscillator | 24.74 | 2.64 |
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
Vinci Compass Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Equity, Equities, Real Assets, Credit, Global IP&S, and Corporate Advisory. The company's majority of its revenue comes from the Private Equity segment, which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.